U028 Pigmentary Potpourri: How to Evaluate, Diagnose, and Treat Pigmentary Conditions
DESCRIPTION
This session will provide a clinical overview of common and uncommon pigmentary conditions. It will discuss diagnostic approaches to evaluating pigmentary conditions and what tools to use to arrive at the correct diagnosis. It will also discuss multimodal therapeutic approaches to these varied conditions and how this can be affected by a patient's skin type. The session will be aimed at dermatologists who are interested in expanding their understanding of pigmentary disorders and how to safely and effectively diagnose and treat these conditions in diverse populations.
LEARNING OBJECTIVES
Provide a clinical overview of a variety of common and uncommon disorders of pigmentation.
Discuss how to effectively diagnose and distinguish between pigmentary conditions using a variety of tools.
Develop appropriate, safe, and effective treatment plans for challenging pigmentary conditions using a multimodal approach.
DIRECTOR
Neelam Vashi, MD, FAAD
CO-DIRECTOR
Nada Elbuluk, MD, FAAD
DISCLOSURES
Nada Elbuluk, MD, FAAD
AbbVie – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Avita Medical – Consultant (1099 relationship)(Fees); Beiersdorf – Advisory Board(Fees), Consultant (1099 relationship)(Fees), Speaker(Fees); Canfield Scientific, Inc. – Consultant (1099 relationship)(Fees); Dior – Advisory Board(Fees); Eli Lilly and Company – Advisory Board(Fees), Investigator(Grants/Research Funding); Galderma Laboratories, L.P. – Advisory Board(Fees); Global Vitiligo Foundation – Board of Directors(No Compensation Received); Incyte Corporation – Advisory Board(Fees), Consultant(Fees); Janssen Biotech – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Kao USA – Consultant (1099 relationship)(Fees); Kenvue – Advisory Board(Fees); L'Oreal USA Inc. – Advisory Board(Fees); McGraw-Hill Companies – Advisory Board(Fees), Other(Other Financial Benefit); Medscape – Speaker(Fees); Pfizer Inc. – Advisory Board(Fees), Investigator(Grants/Research Funding); Sanofi – Advisory Board(Fees); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); Teva Pharmaceuticals USA – Consultant (1099 relationship)(Fees); VeraDermics Inc. – Advisory Board(Fees); VisualDx – Consultant(Fees), Consultant(Stock Options); Women's Dermatologic Society – Board of Directors(No Compensation Received);
Neelam Vashi, MD, FAAD
Biogen – Consultant (1099 relationship)(Honoraria); Canfield Scientific, Inc. – Consultant (1099 relationship)(Honoraria); Janssen Biotech – Consultant(Honoraria); L'Oreal – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria); Procter & Gamble Company – Consultant(Honoraria);